What's new

Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Date of authorisation: 09/11/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Date of authorisation: 09/11/2017, Revision: 12, Status: Authorised

Jun 24, 2025 - 16:30
 0
Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Date of authorisation: 09/11/2017, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Miglustat Gen.Orph, miglustat, Date of authorisation: 09/11/2017, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Opinion/decision on a Paediatric investigation plan (PIP): Tecartus, brexucabtag...

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Sunlenca, Lenacapavir...

Related Posts

Non-current Veterinary Dictionary for Drug Regulatory A...

Jun 27, 2025  0

Human medicines European public assessment report (EPAR): Teriparatide Ascend, teriparatide, Status: Application withdrawn

Human medicines European public assessment report (EPAR...

May 26, 2025  0

Questions and answers on the refusal of the marketing a...

Jun 3, 2025  0